Abstract
To assess the effects of valsartan and amlodipine on the haemodynamics of forearm circulation in hypertensive patients undergoing isometric stress. A total of 24 patients with essential hypertension were subjected to a double blind-cross-over study. The artery left arm flow (strain gauge plethysmography), distensibility of digital arteries (piezoelectric plethysmography) and blood pressure were measured. District resistance was calculated as the ratio between mean arterial pressure and blood flow. The tests were performed at basal conditions (T0) and after 8 days (T8) of therapy with valsartan (160 mg) or amlodipine (10 mg), at rest and during handgrip (HG); treatments were inverted after 15 days of washout. Valsartan and amlodipine reduced blood pressure after 8 days (P<0.05), handgrip increased systolic and diastolic values and heart rate at T0 and only a slight raising in diastolic values at T8. The recovery time of pressure values was longer in hypertensives treated with amlodipine (P<0.05). The forearm flow increased after HG (at T0 an T8) and increased even further after valsartan (P<0.005). Valsartan increased arteriolar distensibility, expressed by the ratio between time to peak and total time (PT/TT) calculated on the sphygmic wave. Amlodipine did not affect PT/TT ratio, whereas it reduced local resistance (T8 vs T0, P<0.05). The reduction effect of valsartan on resistance was detectable also during handgrip, on the contrary amlodipine did not control the increase. Inhibition of AT1 is able to reduce haemodynamic modifications elicited by isometric stress in hypertensive patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stroth U, Unger T . The renin–angiotensin system and its receptors. J Cardiovasc Pharmacol 1999; 33(Suppl 1): S21–S28; discussion s41–s43.
Sealey JE, Laragh JH . The renin–angiotensin–aldosterone system for normal regulation of blood pressure and sodim and potassium homeostasis. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. Raven Press Ltd: New York, NY, 1995, pp 1763–1796.
Zimmerman BG . Adrenergic facilitation by angiotensin: does it serve a physiological funcion? Clin Sci 1981; 60: 343–348.
Hollander AP, Bouman LN . Cardiac acceleration in man elicited by a muscle-heart reflex. J Appl Physiol 1975; 38: 272–278.
Burnier M, Brunner HR . Angiotensin II receptor antagonists. The Lancet 2000; 355: 637–645.
Timmermans PB . Angiotensin II receptor antagonists; an emerging new class of cardiovascular therapeutics. Hypertension Res 1999; 22: 147–153.
Oparil S, Duke S, Harris F, Kief J, James D, Hester A et al. The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension. Clin Ther 1996; 18: 797–810.
Thurmann PA . Angiotensin II antagonism and the heart: valsartan in left biventricular hypertrophy. J Cardiovasc Pharmacol, 1999; 33(Suppl 1): s33–s36; discussion s41–s43.
Cohn JN . Improving outcomes in congestive heart failure: Val-Heft. Valsartan in heart failure trial. Cardiology 1999; 91: 19–22.
Muek A, Seeger H, Lippert TH . Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery. Int J Clin Pharmacol Ther 1999; 37: 365–366.
Peeters AC, Netea MG, Kullberg BJ, Thien T, van der Meer JW . The effect of renin–angiotensin system inhibitors on pro-and anti-inflammatory cytokine production. Immunology 1998; 94: 376–379.
Mervaala EM, Muller DN, Park JK, Schmidt F, Lon M, Breu V et al. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 1999; 33 (Part 2): 389–395.
Gibbons GH . Vasculoprotective and cardioprotective mechanisms of angiotensin-converting inhibition: the homeostatic balance between angiotensin II and nitric oxide. Clin Cardiol 1997; 20 (Suppl 2): II-18–II-25.
Tayeh MA, Scicli AG . Angiotensin II and bradikinin regulate the expression of P-selectin on the surface of endothelial cells in culture. Proc Assoc Am Physicians 1998; 110: 412–421.
Rahn KH, Barenbrock M, Hausberg M . The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens 1999; 17 (Suppl 3): S11–S14.
Ohlsein EH, Brooks DP, Feurestein GZ, Ruffolo Jr RR . Inhibition of sympathetic outflow by the angiotensin II receptor antagonist. Pharmacology 1997; 55: 244–251.
Pancera P, Arosio E, Priante F, Ribul M, De Marchi S, Lechi A . Haemodynamic changes induced by cilazapril and atenolol during isometric stress in hypertensive patients. Int J Clin Pharmacol Ther and Toxicol 1993; 31: 582–587.
Sumner DS . Volume plethysmgraphy in vascular disease: an overview. In: Bernstein EF (ed). Vascular diagnosis. Mosby: St Louis, 1993, pp 181–193.
Pancera P, Sansone S, Secchi S, Covi G, Lechi A . The effect of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon. J Int Med 1997; 242: 373–376.
Kappert A . Oscillografia acrale. In: Angiologia – First italian edition of Lehrbuck und atlas der Angiologie. Verlag Hans Huber: Twelfth edition Berna, 1991, pp 69–71.
Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A . Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium dependent dilation in hypertensive patients undergoing isometric stress. J Hypertens 2002; 20: 1793–1797.
Asmar R . Arterial Pulse Wave. In: Arterial Stiffness and Pulse Wave Velocity Clincal Applications. Elsevier ed.: Paris France, 1999, pp 17–23.
Milasseau SC, Guigui FG, Kelly RP, Prasad K, Crockcroft JR, Ritter JM et al. Non invasive assessment of the digital volume pulse. Hypertension 2000; 36: 952.
Ceru S, Pancera P, Sansone S, Sfondrini G, Codella O, De Sandre G et al. Effects of five day versus one day infusion of iloprost on the peripheral microcirculation in patients with systemic sclerosis. Clin Exp Rheumatol 1997; 15: 381–385.
Grossman E, Oren S, Garavaglia GE, Schmieder R, Messerli FH . Disparate haemodynamic and sympathoadrenergic responses to isometric and mental stress in essential hypertension. Am J Cardiol 1989; 64: 42–44.
Graafsma SJ, Wan Tits LJ, Wan Heijts P, Reyenga J, Rodrigues de Miranda JF et al. Effects of isometric exercise on blood cell adrenoceptors in essential hypertension. J Cardiovasc Pharmacol 1989; 14: 598–602.
Minuz P, Pancera P, Ribul M, Priante F, Degan M, Campedelli A et al. Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition. Br J Clin Pharmacol 1995; 39: 45–50.
Spence JD, Munoz C, Murray WH, Sonya T . Effect of amlodipine on haemodynamic and endocrine responses to mental stress. Am J Hypertens 2000; 13 (Part 1): 518–522.
Nazzaro P, Mnazari M, Merlo M, Triggiani R, Scarano AM, Lasciarrea A et al. Antihypertensive treatment with verapamil and amlodipine. Their effect on the functional autonomic and cardiovascular stress responses. Eur Heart J 1995; 16: 1277–1284.
Sevre K, Lefrandt JD, Eide I, Smit AJ, Rostrup M . Less adrenergic response to mental task during verapamil compared to amlodipine treatment in hypertensive subjects. Blood Press 2001; 10: 111–115.
Widdop RE, Matrougiu K, Levy BI, Henrion D . AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 2002; 40: 516–520.
London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL . Cardiac Hypertrophy, aortic compliance, peripheral resistance and wave reflection in end stage renal disease. Circulation 1994; 90: 2786–2796.
Kalinowski L, Matys T, Chabielska E, Buczko W, Malinski T . Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension 2002; 40: 521–524.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arosio, E., Marchi, S., Prior, M. et al. Haemodynamic effects of AT1 inhibition and Ca2+-channel blockade in hypertensive patients during isometric stress. J Hum Hypertens 20, 201–205 (2006). https://doi.org/10.1038/sj.jhh.1001963
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001963